Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting ...

--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its oncology portfolio will be presented at the 2025 American Society of Clinical Oncology ...

Ascentage Pharma Group Internat (Nasdaq: AAPG) said two of its proprietary drugs have been included in the 2025 Chinese Society of Clinical Oncology (CSCO) Guidelines. The added drugs are ...

In this video, Robert DeBernardo, MD, shares insight on antibody-drug conjugates as treatment for patients with cancer, a topic discussed at Society of Gynecologic Oncology Annual Meeting on Women ...

discusses his research on hyperthermic intraperitoneal chemotherapy among patients with ovarian cancer and underlying kidney disease, which he presented at Society of Gynecologic Oncology Annual ...

O’Connor et al. examined the role of crowdfunding in helping patients with gynecologic cancer offset the financial strain caused by medical and non-medical costs of cancer care, often referred to as ...

I want to move to a hotter topic in endometrial cancer, and that's really around immunotherapy. You gave the invited discussant presentation at the Society of Gynecologic Oncology (SGO ...

In a special article published online March 19 in the Journal of Clinical Oncology, the American Society of Clinical ... and conservative gynecologic surgery. In vitro maturation of oocytes ...

Data were presented by Bobby May Jr, MD, and colleagues at the Society of Gynecologic Oncology 2025 Winter Meeting. 1 Results indicated that among patients in the FRα cohort (n = 80), 82.5% of patient ...